Viking Therapeutics (VKTX) Reports Q2 Loss of $0.22/Share

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.22), versus ($1.07) reported last year.

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Jefferies, UBS downgrade Victoria's Secret as rally leaves limited upside
• Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours